skip navigation

Skip Nav

AIDSinfo Drug Database

Skip Navigation

Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Disoproxil Fumarate  Audio icon

Brand Name: Stribild
Other Names: EVG/COBI/FTC/TDF, QUAD
Drug Class: Combination Drugs
Approved Use: Treatment of HIV Infection
Drug Image:
Click image to enlarge
Chemical Images:
Click image to enlarge
elvitegravir
elvitegravir
Molecular Weight: 447.8877
cobicistat
cobicistat
Molecular Weight: 776.0347
emtricitabine
emtricitabine
Molecular Weight: 247.249
tenofovir disoproxil fumarate
tenofovir disoproxil fumarate
Molecular Weight: 635.5166

WARNING:


Stribild can cause serious, life-threatening side effects. These include lactic acidosis (buildup of lactic acid in the blood) and liver problems.

Contact your health care provider right away if you have any of the following symptoms that may signal lactic acidosis:

  • Weakness or tiredness.
  • Unusual (not normal) muscle pain.
  • Trouble breathing.
  • Stomach pain with nausea and vomiting.
  • Feeling cold, especially in your arms and legs.
  • Dizziness or lightheadedness.
  • Fast or irregular heartbeat.

Contact your health care provider right away if you have any of the following symptoms that may signal liver problems:

  • Yellowing of your skin or the whites of your eyes (jaundice).
  • Dark-colored urine.
  • Light-colored bowel movements.
  • Loss of appetite for several days or longer.
  • Feeling sick to your stomach (nausea).
  • Pain in the stomach area (abdominal pain).

Stribild is not approved for the treatment of hepatitis B virus (HBV) infection. If you have both HIV and HBV infection and take Stribild, your HBV infection may get worse (flare up) if you stop taking Stribild. The HBV drug adefovir dipivoxil (brand name: Hepsera) should not be taken with Stribild.

While taking Stribild, it is important to keep all of your appointments with your health care provider.


What is Stribild?


Stribild is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV infection in adults who have never taken HIV medicines before. Stribild is a complete regimen for the treatment of HIV infection and should not be used with other HIV medicines.

Stribild contains the following four different medicines combined in one pill: 

  • Elvitegravir - an HIV medicine called an integrase inhibitor. 
  • Cobicistat – a medicine called a pharmacokinetic enhancer, used to increase the effectiveness of elvitegravir.
  • Emtricitabine – an HIV medicine called a nucleoside reverse transcriptase inhibitor (NRTI).
  • Tenofovir disoproxil fumarate – another HIV medicine (also an NRTI). 

Integrase inhibitors block an HIV enzyme called integrase. (An enzyme is a protein that starts or increases the speed of a chemical reaction.) NRTIs block an HIV enzyme called reverse transcriptase. By blocking integrase and reverse transcriptase, the drugs in combination prevent HIV from multiplying and can reduce the amount of HIV in the body.

Stribild does not cure HIV/AIDS. People with HIV should stay on continuous HIV treatment as directed by their health care provider and should take steps to avoid passing HIV to others (for example, using a condom during sex).


What should I tell my health care provider before taking Stribild?


Before taking Stribild, tell your health care provider:
 
  • If you are allergic to any of the HIV medicines in Stribild (elvitegravir, cobicistat, emtricitabine, or tenofovir disproxil fumarate) or any other medicines.
  • If you have liver problems, including HBV infection.
  • If you have kidney problems.
  • If you have bone problems.
  • If you have any other medical conditions.
  • If you are pregnant or plan to become pregnant. Whether Stribild can harm an unborn baby is unknown.
  • If you are breastfeeding or plan to breastfeed. Do not breastfeed if you are infected with HIV or are taking Stribild.
  • About other prescription and nonprescription medicines, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Stribild may affect the way other medicines or products work, and other medicines or products may affect how Stribild works. Taking Stribild together with certain medicines or products may cause serious and/or life-threatening side effects.


How should I take Stribild?


Stribild comes in tablet form. Each tablet contains:
 
  • 150 mg elvitegravir.
  • 150 mg cobicistat.
  • 200 mg emtricitabine (brand name: Emtriva).
  • 300 mg tenofovir disproxil fumarate (brand name: Viread).

Take Stribild according to your health care provider’s instructions.

Take Stribild with food. Do not take Stribild with other HIV medicines.

If you take too much Stribild, contact your health care provider or local poison control center (1-800-222-1222) right away, or go to the nearest hospital emergency room.

For more information on how to take Stribild, see the FDA drug label from DailyMed. (DailyMed is a federal website that includes the most recent drug labels submitted to FDA.)


What should I do if I forget a dose?


Take the missed dose as soon as you remember it. But if it is almost time for your next dose, skip the missed dose and just take your next dose at the regular time. Do not take two doses at the same time to make up for a missed dose.


What side effects can Stribild cause?


Stribild can cause serious, life-threatening side effects. These include lactic acidosis (buildup of lactic acid in the blood) and liver problems. (See the WARNING above).

 Other possible side effects of Stribild include:

  • New or worsening kidney problems, including kidney failure.
  • Bone problems (bone pain, softening, or thinning [osteopenia]).
  • Changes in body fat (lipodystrophy).
  • Changes in the immune system (immune reconstitution inflammatory syndrome [IRIS]).

Tell your health care provider if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects of Stribild. Ask your health care provider or pharmacist for more information on side effects of Stribild. You may also want to read this fact sheet about HIV medicines and side effects.

You may report side effects to FDA at 1-800-FDA-1088 (1-800-332-1088).


How should Stribild be stored?


  • Store Stribild at room temperature, 68°F to 77°F (20°C to 25°C).
  • Keep Stribild in the container that it came in and keep the container tightly closed. If the container has a small packet of drying agent (called a desiccant), do not remove it. The desiccant protects the medicine from moisture.
  • Do not use Stribild if the original seal over the bottle opening is broken or missing.
  • Safely throw away Stribild that is no longer needed or expired (out of date).
  • Keep Stribild and all medicines out of reach of children.


Where can I find more information about Stribild?



Manufacturer Information


Gilead Sciences
800-445-3235


The above Patient Version drug summary is based on the following FDA label(s): Tablet.


Last Reviewed: March 13, 2014

Last Updated: March 13, 2014